Low molecular weight heparin and radical prostatectomy: a prospective analysis of safety and side effects


We prospectively analyzed the safety of the perioperative use of low molecular weight heparin (LMWH) for prophylaxis of thromboembolic complications after radical retropubic prostatectomy (RRP).Seventy-three consecutive patients received Enoxaparin, a LMWH compound one hour before RRP and then every twelve hours until hospital discharge. A mean of seven… (More)
DOI: 10.1038/sj.pcan.4500214


4 Figures and Tables

Slides referencing similar topics